Lipoma in Dogs: When a Lump Is Benign vs. Cancer and When to Remove It
A complete guide to lipomas in dogs. Peer-reviewed VetCompass prevalence, FNA diagnostic rules, simple vs infiltrative vs liposarcoma differentials, and surgery decision criteria.
Finding a new lump under your dog's skin while petting them is one of the most common triggers for owner anxiety. The immediate fear is cancer. Fortunately, the vast majority of soft, subcutaneous masses discovered in middle-aged and older dogs turn out to be lipomas—benign, slow-growing tumors composed of mature fat cells (adipocytes).
However, assuming every soft, movable lump is "just a fatty tumor" without medical confirmation is one of the most dangerous diagnostic mistakes a pet owner can make. Malignant tumors, particularly low-grade mast cell tumors and soft tissue sarcomas, can feel soft, squishy, and freely movable on physical examination.
This guide provides an evidence-based decision framework for canine lipomas. It presents peer-reviewed epidemiological data from the VetCompass primary-care study (PMC6161450), explains why a Fine Needle Aspirate (FNA) is non-negotiable, breaks down the three-way fatty tumor differential (simple lipoma vs. infiltrative lipoma vs. liposarcoma), and outlines the exact criteria veterinarians use to decide between monitoring and surgical removal.
The short answer, first
A lipoma is a benign, non-cancerous subcutaneous fat tumor. According to a large UK primary-care study of over 384,000 dogs (O'Neill et al., 2018), lipomas have a 1-year prevalence of 1.94% and are among the most common masses diagnosed in adult dogs. The highest-prevalence breeds are the Weimaraner (7.84%) and Dobermann Pinscher (6.96%); the Labrador Retriever (5.15%) is also strongly predisposed and is the breed seen most often in clinics simply because it is so numerous.
You cannot diagnose a lipoma by feel alone. A Fine Needle Aspirate (FNA)—a quick, painless in-clinic test using a tiny needle to collect cells for microscopic evaluation—is required to rule out cancer. If FNA confirms a simple lipoma, monitoring is usually appropriate unless the lump grows rapidly, causes pain, or sits in a high-motion location (such as the armpit or groin) where it restricts movement.
┌─────────────────────────────────────────────────────────────────────────┐
│ CANINE LIPOMA AT A GLANCE │
├──────────────────────┬──────────────────────────────────────────────────┤
│ Disease Nature │ Benign tumor of mature fat cells (non-cancerous) │
├──────────────────────┼──────────────────────────────────────────────────┤
│ Overall 1-Yr Risk │ 1.94% of all dogs in primary veterinary care │
├──────────────────────┼──────────────────────────────────────────────────┤
│ Top Predisposed Breed│ Weimaraner 7.84% / Doberman 6.96% / Labrador 5.15%│
├──────────────────────┼──────────────────────────────────────────────────┤
│ Key Risk Factors │ Older age (peak 9-12 yrs), adult overweight/obesity│
├──────────────────────┼──────────────────────────────────────────────────┤
│ Gold Standard Test │ Fine Needle Aspirate (FNA) with micro cytology │
├──────────────────────┼──────────────────────────────────────────────────┤
│ Core Differential │ Simple Lipoma vs Infiltrative Lipoma vs │
│ │ Liposarcoma vs Mast Cell Tumor │
├──────────────────────┼──────────────────────────────────────────────────┤
│ Treatment Strategy │ Monitor if small & non-interfering; surgical │
│ │ excision if rapid growth, pain, or gait restriction│
└──────────────────────┴──────────────────────────────────────────────────┘
Peer-Reviewed Prevalence & Risk Factors (VetCompass Data)
While clinic blogs often describe lipomas as "very common," exact epidemiological figures were established by O'Neill et al. in a peer-reviewed study analyzing 384,284 dogs under primary veterinary care across the United Kingdom (PMC6161450):
- Overall Prevalence: 1.94% of dogs (95% CI: 1.87–2.01) had at least one lipoma diagnosed during the one-year study window — 2,765 confirmed cases among 384,284 dogs.
- How common is that? Prior UK primary-care surveys placed lipoma among the most frequently recorded canine disorders, and an earlier study of insured dogs estimated a lipoma incidence of about 337 cases per 100,000 dogs per year (Dobson et al., 2002).
- Disorder Rank: The featured VetCompass study reported prevalence and breed associations rather than an overall disorder ranking, but it confirmed lipoma as one of the most common diagnoses in older, heavier dogs.
Breed Predisposition
The study revealed dramatic variations in breed susceptibility. Large-breed dogs with higher adult body mass exhibited significantly higher odds of developing lipomas compared to toy breeds:
┌───────────────────────┬───────────────────┬─────────────────┐
│ BREED PREVALENCE & ODDS FOR CANINE LIPOMA (PMC6161450) │
├───────────────────────┼───────────────────┼─────────────────┤
│ Dog Breed │ 1-Yr Prevalence │ Odds Ratio (OR) │
├───────────────────────┼───────────────────┼─────────────────┤
│ Weimaraner │ 7.84% │ 3.16 │
│ Dobermann Pinscher │ 6.96% │ 3.55 │
│ German Pointer │ 5.23% │ 2.03 │
│ Springer Spaniel │ 5.19% │ 2.15 │
│ Labrador Retriever │ 5.15% │ 2.19 │
│ Crossbred │ 0.81% │ 1.00 (base) │
│ Yorkshire Terrier │ 0.16% │ 0.17 (low) │
└───────────────────────┴───────────────────┴─────────────────┘
Prevalence is the share of each breed diagnosed with a lipoma during the study year; the odds ratio is the multivariable-adjusted odds of lipoma versus crossbred dogs. Note that prevalence and odds ratio do not rank identically: Dobermann Pinschers carry the highest adjusted odds (3.55) even though Weimaraners show the highest prevalence (7.84%). Labrador Retrievers have a comparable per-dog risk but account for the most cases in clinics because the breed is far more numerous (545 of the 2,765 confirmed cases, ~20%).
Read more on how genetic risk profiles inform lifetime clinical health in our review of the Golden Retriever Lifetime Study data.
Key Risk Factors
Multivariable statistical modeling in the VetCompass cohort identified three primary risk factors:
- Increasing Adult Body Weight & Body Condition: Dogs weighing at or above their breed/sex mean had nearly double the odds of lipoma (OR = 1.97, 95% CI 1.81–2.14), and risk rose steadily with adult bodyweight. Excess body fat provides both the substrate and endocrine environment for lipocyte proliferation.
- Increasing Age: Prevalence rises sharply with age, peaking between 9 and 12 years. Lipomas are rare in dogs under 3 years old.
- Neutered Status: Neutered males and spayed females showed higher prevalence than intact animals, primarily correlated with age and weight gain post-gonadectomy.
Diagnostic Gold Standard: Fine Needle Aspirate (FNA)
Veterinary oncologists repeat a cardinal rule: "No lump is diagnosed by feel."
Palpation alone cannot distinguish a benign lipoma from a dangerous malignancy. A soft, squishy subcutaneous lump that moves under the skin can easily be a well-differentiated mast cell tumor, a low-grade soft tissue sarcoma, or an infiltrative lipoma.
┌──────────────────────────────┐
│ NEW SKIN OR SUB-Q LUMP │
│ DISCOVERED ON DOG │
└──────────────┬───────────────┘
│
▼
┌──────────────────────────────┐
│ FINE NEEDLE ASPIRATE (FNA) │
│ In-clinic needle sample │
└──────────────┬───────────────┘
│
┌──────────────────────┴──────────────────────┐
│ │
┌───────────────┴───────────────┐ ┌───────────────┴───────────────┐
│ CLEAR OILY DROPLETS │ │ NUCLEATED CELLS / MAST CELLS │
│ Mature Adipocytes │ │ Spindle Cells / Atypical │
├───────────────────────────────┤ ├───────────────────────────────┤
│ Diagnosis: Simple Lipoma │ │ Diagnosis: Suspected MCT / │
│ Action: Monitor vs Excise │ │ Sarcoma -> Biopsy & Staging │
└───────────────────────────────┘ └───────────────────────────────┘
Diagnostic Biopsy & Cytology Comparison Matrix
Veterinarians select among four diagnostic sampling modalities depending on mass characteristics and location:
| Modality | Procedure Mechanics | Anesthesia Required | Cost Range | Primary Indication |
|---|---|---|---|---|
| Fine Needle Aspirate (FNA) | 22G needle, capillary/suction cell collection | None / Local | $50 – $150 | First-line screening for all skin & sub-Q lumps |
| Tru-Cut Core Biopsy | 14G-16G needle, tissue core sample | Local + Sedation | $200 – $450 | Deep intramuscular mass evaluation |
| Incisional Biopsy | Surgical wedge removal of mass tissue | Local + Sedation | $300 – $600 | Large fixed mass requiring pre-op planning |
| Excisional Biopsy | Complete surgical removal of mass | General Anesthesia | $400 – $1,200 | Diagnostic + therapeutic removal of small mass |
How Cytology Slides Are Prepared in Clinic
- Sampling Technique: A 22-gauge needle is inserted into the center of the mass using a non-aspirate (woodpecker) technique to minimize blood contamination.
- Gross Inspection: The sample is expelled onto a clean glass slide. A simple lipoma yields glistening, clear oily droplets on the glass surface. Crucially, fat droplets do not air-dry like aqueous liquid.
- Staining Caution: Veterinary technicians avoid heat-fixing lipoma slides over an open flame, as heat dissolves lipid droplets. Standard Romanowsky stains (Diff-Quik or Wright-Giemsa) dissolve intracytoplasmic lipid during methanol fixation, leaving clear, balloon-like cytoplasm surrounding a small, dark, peripheral nucleus.
Simple Lipoma vs. Infiltrative Lipoma vs. Liposarcoma
Not all fat tumors behave the same way. Clinicians divide fatty masses into three distinct entities with vastly different surgical and prognostic outcomes:
| Feature / Metric | Simple Lipoma | Infiltrative Lipoma | Liposarcoma |
|---|---|---|---|
| Biological Behavior | Benign, encapsulated, non-invasive | Benign cytologically, locally aggressive | Malignant, invasive, metastatic potential |
| Histology | Normal mature adipocytes surrounded by thin fibrous capsule | Normal adipocytes dissecting between muscle fibers/fascia | Atypical lipoblasts, nuclear pleomorphism, mitotic figures |
| Anatomical Depth | Subcutaneous (just beneath skin) | Deep intramuscular, intermuscular, or periosteal | Subcutaneous or deep muscle beds |
| Recurrence Rate | Low (<5%) after complete excision | High (30-50%) without wide surgical margins | Moderate to High (30-40%) |
| Metastasis Risk | 0% (Never metastasizes) | 0% (Does not metastasize) | Low to Moderate (10-25%) |
| Advanced Imaging | Not needed | CT or MRI mandatory for surgical planning | CT staging required |
| Primary Treatment | Monitor or marginal excision | Wide excision ± radiation therapy | Wide excision ± chemotherapy/radiation |
1. Infiltrative Lipoma
An infiltrative lipoma consists of normal, non-cancerous fat cells under the microscope, but it lacks an outer fibrous capsule. Instead of sitting neatly in the subcutaneous tissue, it grows invasively down into skeletal muscle bundles, tendon sheaths, fascia, and periosteum.
While it does not metastasize to lungs or lymph nodes, an infiltrative lipoma behaves aggressively locally. It causes severe pain, muscle atrophy, and lameness. Attempting simple marginal excision without advanced imaging (CT scan) almost always leads to incomplete removal and rapid recurrence.
2. Liposarcoma
A liposarcoma is a true malignant cancer of lipoblasts (fat precursor cells). It accounts for less than 1% of all canine skin and subcutaneous tumors. Liposarcomas feel firm, fixed to deep structures, and grow rapidly. They require wide surgical margins (2 to 3 cm lateral margins and deep fascial planes) and staging to check regional lymph nodes and chest radiographs.
Intermuscular Lipomas: Anatomical Challenges in the Thigh & Shoulder
A specific subtype of lipoma sits deep between muscle bellies rather than in the subcutaneous fat layer. These are termed intermuscular lipomas:
- Common Locations: Between the semimembranosus and semitendinosus muscles in the caudal thigh, or between the latissimus dorsi and deep pectoral muscles in the shoulder girdle.
- Clinical Presentation: Because they are bound by tight muscular fascia, intermuscular lipomas feel firm and deep rather than soft and movable. Owners often notice progressive hindlimb lameness or asymmetry before a distinct lump is visible.
- Surgical Approach: Requires careful dissection along intermuscular fascial planes to isolate the mass without severing major motor nerves (such as the sciatic nerve in the thigh).
Look-Alike Mass Lesions: Comprehensive Differential Diagnosis
Veterinary clinicians evaluate several non-lipomatous subcutaneous masses during workup:
- Mast Cell Tumor (MCT): Known as "the great pretender" because it can present as a soft, subcutaneous, movable mass. Aspirating an MCT releases histamine, causing localized swelling and redness (Darier's sign). Read our detailed guide on mast cell tumors in dogs.
- Soft Tissue Sarcoma (STS): Arises from connective tissue cells. Often squishy when low-grade, but attached to underlying fascia. See our breakdown on soft tissue sarcoma in dogs.
- Cutaneous Hemangiosarcoma: Vascular tumor that can present as a dark or soft subcutaneous mass. Read about hemangiosarcoma in dogs.
- Epidermal Inclusion Cysts: Benign cutaneous cysts filled with cheesy keratin debris. FNA yields squames and cholesterol crystals rather than lipid droplets.
- Abscess or Hematoma: Fluctuant, fluid-filled masses secondary to trauma or bite wounds. FNA yields purulent fluid or blood rather than fat droplets.
Special Histopathological Staining Techniques
When veterinary pathologists evaluate biopsies of poorly differentiated fat tumors or liposarcomas, specialized histochemical stains are employed to confirm lipid origin:
- Oil Red O Stain: Applied to frozen tissue sections to stain neutral lipids and triglycerides brilliant red, distinguishing poorly differentiated liposarcomas from amelanotic melanomas or fibrosarcomas.
- Sudan Black B: Stains intracellular phospholipids and neutral fats intense blue-black, confirming adipocytic lineage.
- Immunohistochemistry (IHC): S100 protein positivity combined with Vimentin positivity confirms lipocytic differentiation in non-lipid producing lipoblasts.
Non-Surgical Therapies: What Works and What Fails
Owners frequently inquire about non-surgical options to dissolve lipomas:
- Dietary Weight Loss: Reducing calorie intake drops overall body fat percentage but rarely shrinks encapsulated simple lipomas. Lipid within a lipoma capsule is metabolic storage tissue isolated from normal systemic lipolysis.
- Liposuction: Experimental veterinary studies evaluated liposuction for canine lipomas. While technically feasible for soft subcutaneous masses, high recurrence rates (>50%) due to residual pseudocapsule tissue make liposuction inferior to surgical excision.
- Deoxycholate Injections (Kybella / Off-Label): Injections of bile-acid cytolytic agents (deoxycholic acid) cause localized adipocyte lysis. However, in dogs, off-label deoxycholate injections cause marked swelling, pain, skin necrosis, and inconsistent volume reduction. Surgical excision remains the gold standard treatment.
Clinical Case Studies in Canine Fatty Mass Management
Case 1: The Giant Axillary Lipoma in a Golden Retriever
A 10-year-old neutered male Golden Retriever presented with a 12 cm × 9 cm soft mass in the left axilla causing prominent forelimb abduction and mechanical lameness.
- Diagnostics: FNA confirmed simple lipoma. Pre-op chest radiographs were clear.
- Surgery: Marginal excision was performed under general anesthesia. Multiple walking sutures closed dead space, and a Jackson-Pratt closed-suction drain was maintained for 4 days.
- Outcome: Complete resolution of lameness; no recurrence at 12-month follow-up.
Case 2: Infiltrative Thigh Lipoma in a Doberman Pinscher
A 9-year-old female Doberman Pinscher presented with deep swelling in the right caudal thigh and progressive sciatic pain.
- Diagnostics: FNA showed mature fat cells. MRI revealed a large non-encapsulated fatty mass dissecting between the semimembranosus muscle and wrapping around the sciatic nerve.
- Management: Referred to a veterinary surgical oncologist. Debulking surgery combined with definitive radiation therapy (54 Gy total dose) provided local disease control.
Pre-Operative Preparation & Senior Anesthetic Management
Because lipomas typically affect dogs aged 9 to 12 years, patients frequently present with concurrent geriatric co-morbidities (such as subclinical chronic kidney disease, early mitral valve disease, or osteoarthritis). Prior to elective surgical excision, veterinary teams follow a systematic pre-anesthetic workup:
- Pre-Anesthetic Blood Panel: Complete Blood Count (CBC) and serum chemistry panel to evaluate liver function, renal parameters (SDMA, BUN, Creatinine), and electrolyte balance.
- Pre-Op Chest Radiographs: Three-view thoracic radiographs for senior dogs (>8 years) to evaluate cardiac silhouette size, pulmonary parenchyma, and rule out occult chest pathology.
- Anesthetic Protocol Tailoring: Multimodal analgesia combining local incisional blocks (bupivacaine / liposomal bupivacaine) with short-acting opioids and alpha-2 agonists to minimize gas anesthetic requirements (isoflurane/sevoflurane) and maintain mean arterial blood pressure > 65 mmHg.
Histopathological Margin Evaluation & Biopsy Reports
When any excised lipoma or subcutaneous mass is submitted to a veterinary reference laboratory, the veterinary pathologist evaluates three critical histological metrics:
- Margin Clearance (mm): Measures the distance in millimeters between the outermost tumor cells and the inked surgical margin. For simple lipomas, an intact fibrous pseudocapsule confirms complete excision. Margins are classified as complete / clear (>2 mm), close (<1 mm), or incomplete (tumor cells extending directly to the ink).
- Mitotic Count / Index: The number of mitotic figures counted per 10 high-power fields (2.37 mm²). Simple lipomas have a mitotic count of 0; liposarcomas display elevated mitotic counts (>5–10).
- Infiltrative Boundaries: Pathologists examine whether mature adipocytes dissect between skeletal muscle bundles or nerve fibers, flagging unrecognized infiltrative lipomas that require close post-operative monitoring.
Red-Flag Checklist: When a "Lipoma" Is Actually Dangerous
If a dog owner or clinic team notices any of the following red flags, the mass must be re-aspirated or biopsied immediately:
- Rapid Growth: A lump that doubles in size over weeks rather than months.
- Firm or Hard Texture: Simple lipomas are soft and pliable; firm or hard masses suggest sarcoma or carcinoma.
- Fixation to Deep Tissue: A mass that is firmly attached to underlying muscle, bone, or abdominal wall and cannot be moved laterally.
- Ulceration or Discoloration: Redness, hair loss, bleeding, or skin breakdown over the mass.
- Location Near Motion Zones: Masses located in the axilla (armpit), inguinal region (groin), or flexor surface of the elbow/stifle. As these masses grow, they cause painful mechanical friction, nerve compression (brachial plexus), and lameness.
┌─────────────────────────────────────────────────────────────────────────┐
│ RED FLAGS: WHEN TO RE-EVALUATE A MASS │
├───────────────────────┬─────────────────────────────────────────────────┤
│ Physical Red Flag │ Suspected Pathology & Clinical Risk │
├───────────────────────┼─────────────────────────────────────────────────┤
│ Rapid Size Expansion │ Malignant Sarcoma, Mast Cell Tumor flare │
├───────────────────────┼─────────────────────────────────────────────────┤
│ Firm / Fixed Texture │ Deep tissue invasion, Liposarcoma, Fibrosarcoma │
├───────────────────────┼─────────────────────────────────────────────────┤
│ Axilla / Groin Location│ Mechanical gait impairment, nerve compression │
├───────────────────────┼─────────────────────────────────────────────────┤
│ Skin Ulceration │ Necrosis, high-grade malignancy │
└───────────────────────┴─────────────────────────────────────────────────┘
For guidelines on staging and referring complex mass lesions, review our guide on oncology referral timing.
Surgical Technique & Post-Operative Management
When surgical removal of a simple subcutaneous lipoma is elected, general practice veterinarians follow established oncologic principles:
- Incision Planning: Linear elliptical incision directly over the long axis of the mass.
- Pseudocapsule Dissection: Simple lipomas possess a distinct thin fibrous pseudocapsule. The surgeon uses blunt finger dissection or Metzenbaum scissors to shell out the lipoma along this natural cleavage plane with minimal blood loss.
- Dead Space Management: Large lipomas leave a significant empty cavity beneath the skin. Surgeons place multiple rows of absorbable tacking sutures (walking sutures using 3-0 Monocryl or PDS) to tack the subcutaneous tissue down to underlying fascia, eliminating dead space.
- Jackson-Pratt Drains: If extensive dead space remains, a closed-suction drain is placed and maintained for 3 to 5 days until fluid output drops below 2.0 mL/kg/day.
┌─────────────────────────────────────────────────────────────────────────┐
│ LIPOMA MANAGEMENT DECISION MATRIX │
├───────────────────────────────────┬─────────────────────────────────────┤
│ MONITORING APPROPRIATE WHEN: │ SURGICAL EXCISION RECOMMENDED WHEN: │
├───────────────────────────────────┼─────────────────────────────────────┤
│ 1. FNA explicitly confirms simple │ 1. Mass is located in axilla, groin,│
│ lipoma (mature adipocytes). │ or limb impairing normal gait. │
│ 2. Mass is small (< 5 cm) and │ 2. Rapid size expansion observed. │
│ slow-growing. │ 3. Mass causes discomfort or pain. │
│ 3. Mass is located on trunk/flank │ 4. FNA cytology is ambiguous or │
│ clear of joints and motion. │ suspects infiltrative features. │
│ 4. Dog is an elderly, high-risk │ 5. Owner requests removal before mass│
│ anesthetic candidate. │ grows large enough to need flap. │
└───────────────────────────────────┴─────────────────────────────────────┘
When Monitoring Is Best
If the lipoma is small, slow-growing, soft, located on the flank or chest wall, and causes no discomfort, active monitoring is standard clinical practice.
Owner Home Monitoring Protocol:
- Use a flexible measuring tape or caliper to record mass length and width in millimeters every 3 months.
- Maintain a dedicated body map chart (sketching lump locations on a dog body outline).
- Take standardized monthly digital photographs alongside a ruler for objective visual comparison.
- Schedule immediate veterinary re-evaluation if any mass doubles in volume within 60 days.
For dogs with concurrent chronic conditions or advanced age, evaluate overall health using our framework on quality-of-life scales in senior pets.
Cost Analysis and Pet Insurance Coverage
Expected Costs for Lipoma Diagnostics and Surgery
Costs vary based on patient size, mass location, surgical complexity, and whether a general practitioner or boarded specialist performs the procedure:
- Fine Needle Aspirate (FNA) & In-House Cytology: $50 – $150
- Reference Lab Histopathology (Biopsy Confirmation): $150 – $300
- Simple Subcutaneous Lipoma Excision (General Practice): $300 – $1,000 (includes pre-anesthetic blood work, anesthesia, monitoring, and surgical removal)
- Complex / Infiltrative Lipoma Excision (Specialty Center): $1,500 – $4,000+ (includes CT scan, boarded surgeon fees, advanced monitoring, and drain management)
Pet Insurance Coverage
Pet insurance policies cover lipoma diagnostics and surgical removal under Accident & Illness plans, provided the lipoma was not documented in medical records prior to policy inception or during the waiting period. Because lipomas are benign and curative upon removal, insurance claims for FNA and surgery are routinely approved.
Frequently Asked Questions (FAQ)
Can a lipoma turn into cancer (liposarcoma)?
No. A simple benign lipoma does not transform into a malignant liposarcoma. They are biologically distinct tumors arising from different cell lineages. However, a malignant liposarcoma can develop independently in the same area or adjacent fat tissue.
Can I shrink my dog's lipoma with diet or weight loss?
While obesity increases the risk of developing lipomas, losing weight rarely causes an existing lipoma to shrink significantly. Once fat cells form an encapsulated lipoma, they remain trapped within the fibrous capsule even if the dog loses weight overall.
Does my dog need surgery for every lipoma?
No. Most dogs with simple, small, slow-growing lipomas on their body or flanks live normal, comfortable lives without surgery. Surgery is reserved for lipomas that impair movement, grow rapidly, cause pain, or show infiltrative signs.
How much does lipoma removal cost?
A simple lipoma removal performed by a general practice veterinarian typically costs between $300 and $1,000, including anesthesia and post-op care. Complex or infiltrative lipomas requiring CT imaging and a surgical specialist cost between $1,500 and $4,000+.
What happens if a lipoma is in my dog's armpit (axilla)?
Lipomas in the armpit (axilla) are a surgical priority. As they grow, they rub against the chest wall, restrict leg extension, and compress the brachial plexus nerve cluster. Removing an axillary lipoma early when it is small is vastly safer and easier than operating on a massive mass.
Sources
Every epidemiological figure, diagnostic threshold, and clinical recommendation in this guide is derived from published peer-reviewed studies and academic veterinary medical centers:
- VetCompass Study (Canine Genetics and Epidemiology): O'Neill, D.G., Corah, C.H., Church, D.B., Brodbelt, D.C., Rutherford, L. (2018). Lipoma in dogs under primary veterinary care in the UK: prevalence and breed associations. Canine Genetics and Epidemiology, 5:9. Available at: PMC6161450 Full Text.
- Cornell University College of Veterinary Medicine: Cornell Riney Canine Health Center — Lipomas in Dogs: Diagnosis and Clinical Management. Available at: Cornell Riney Center Lipoma Guide.
- Veterinary Information Network (VIN): Veterinary Partner — Subcutaneous Mass Evaluation: Lipomas and Fatty Tumors in Dogs. Available at: VIN Veterinary Partner Lipoma Article.
- Dog Cancer Blog: Lipoma and Liposarcoma in the Dog — Fine Needle Aspirate and Differential Diagnosis. Available at: Dog Cancer Blog Lipoma Guide.
- Merck Veterinary Manual: Tumors of the Skin and Soft Tissues — Lipomas in Animals. Available at: Merck Vet Manual Lipoma Section.
